Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Canada Postdoctoral Research Award (CPRA) program

Direct Payment

$140,000.00

Immunological mechanisms of Alzheimer's disease progression by chronic herpesvirus infections and vaccination

EF 2025-26

Résumé
Alzheimer's disease (AD) is the most common cause of dementia, affecting over 50 million people worldwide, with cases expected to double in the next 20 years. Memory loss that interferes with daily activities is one of the most well-known traits of AD, posing heavy emotional and financial burdens for families. There is a critical need to understand what initiates AD, and identify those at highest risk. Fortunately, there are some answers already - we know that two abnormal proteins, amyloid beta and tau, accumulates in the AD brain. Additionally, people that are carriers of the APOE4 gene are at disproportionate high risk. Nonetheless, it is still unclear what leads to abnormal protein accumulation in the first place. Almost everyone carries herpesviruses, which can cause cold sores, chickenpox, shingles, and mono-and once inside, they never leave. These viruses can reactivate in times of stress or when the immune system is weakened. Interestingly, studies suggest that people who received vaccinations for shingles may have a lower risk of developing dementia, but the reasons are unclear. This project will test the idea that lifelong infections with herpesviruses, which require a constant surveillance by the immune system to remain quiet, leaves "footprints" on the immune system to influence AD risk and progression. We will use mouse models of AD to answer three questions: 1) Do herpesvirus infections or reactivations worsen cognition and brain disease?; 2) How do vaccinations, such as the shingles vaccine, protect against AD?; and 3) Do antiviral immune cells (such as T cells) play protective or pathological function during AD? By utilizing infection models, vaccination strategies, and immune cell profiling, this research will reveal how exposure to common viruses can leave a lasting mark on the immune system. And while dementia may take away memories, the immune system never forgets - which could hold key to preventing or slowing disease.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
537832
Name
Wang Anran (Angela)
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Immunological mechanisms of Alzheimer's disease progression by chronic herpesvirus infections and vaccination
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Alzheimer'S Disease; Herpesvirus; Immunology; Mouse Models; Neurodegeneration; Neuroimmunology; Rna Sequencing; Viral Infections
Abstract
Alzheimer's disease (AD) is the most common cause of dementia, affecting over 50 million people worldwide, with cases expected to double in the next 20 years. Memory loss that interferes with daily activities is one of the most well-known traits of AD, posing heavy emotional and financial burdens for families. There is a critical need to understand what initiates AD, and identify those at highest risk. Fortunately, there are some answers already - we know that two abnormal proteins, amyloid beta and tau, accumulates in the AD brain. Additionally, people that are carriers of the APOE4 gene are at disproportionate high risk. Nonetheless, it is still unclear what leads to abnormal protein accumulation in the first place. Almost everyone carries herpesviruses, which can cause cold sores, chickenpox, shingles, and mono-and once inside, they never leave. These viruses can reactivate in times of stress or when the immune system is weakened. Interestingly, studies suggest that people who received vaccinations for shingles may have a lower risk of developing dementia, but the reasons are unclear. This project will test the idea that lifelong infections with herpesviruses, which require a constant surveillance by the immune system to remain quiet, leaves "footprints" on the immune system to influence AD risk and progression. We will use mouse models of AD to answer three questions: 1) Do herpesvirus infections or reactivations worsen cognition and brain disease?; 2) How do vaccinations, such as the shingles vaccine, protect against AD?; and 3) Do antiviral immune cells (such as T cells) play protective or pathological function during AD? By utilizing infection models, vaccination strategies, and immune cell profiling, this research will reveal how exposure to common viruses can leave a lasting mark on the immune system. And while dementia may take away memories, the immune system never forgets - which could hold key to preventing or slowing disease.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Wang, Anran (Angela)
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~